Abhideep Roy
banner
abhideeproy.bsky.social
Abhideep Roy
@abhideeproy.bsky.social
PhD student, Neuroscience, CSIR Fellow, Investigating Alzheimer's disease crosstalk with metabolic syndrome | Using Bioinformatics, Machine Learning and AI in research.

#Braindisease #Drugdiscovery #Academia
Pinned
Sharing the first review paper of my PhD journey, deciphering mechanistic insights into CKD and AD crosstalk. Published online on 9th May, and in issue on 21st May in ACS Chemical Neuroscience.
pubs.acs.org/doi/10.1021/...
The Vicious Consequences of Chronic Kidney Disease on Cognitive Impairment and Alzheimer’s Disease
Chronic kidney disease (CKD) and Alzheimer’s disease (AD) are two prevalent and debilitating conditions that frequently coexist, with CKD contributing to cognitive decline and potentially exacerbating...
pubs.acs.org
I will be joining online the Neuroscience & Cell Biology Symposium, 2025 at NUS, Singapore, organising by Singapore Neuroscience Association (IBRO Member). Eagerly waiting to hear exciting brain research from the global experts.
ibro.org/event/neuros...
ibro.org
June 29, 2025 at 6:36 PM
Neuroscience is becoming a new age religion, where brain study is the most intricate and undiscovered knowledge we are seeking.
June 29, 2025 at 5:14 PM
In India, once you complete your MS, go for JRF exams conducted by CSIR/DBT/ICMR. These funding agencies help you do your PhD with financial freedom, which is highly appreciated. I joined a PhD program with CSIR JRF, always grateful to the agency.
June 8, 2025 at 7:06 AM
I spent the day reviewing an article by a MS student under my guidance, where he discussed the neuroinflammatory crosstalk between JAK/STAT and TGF beta signalling in Parkinson's disease. He has also highlighted the possible therapeutic targets involved in these mechanistic pathways.
June 5, 2025 at 8:37 PM
It could be interesting if you share the link of article. Congratulations btw!!
June 2, 2025 at 9:36 PM
Every rejection makes you rethink about your MS and improve it with better ideas. Refinement of the MS ultimately leads to its acceptance in a reputed and high impact journal.
June 2, 2025 at 9:35 PM
Glad to hear that!! Hope for the best.
May 31, 2025 at 8:25 PM
All are research articles or review/short communication/letters/mini review etc. combined?
May 31, 2025 at 3:12 PM
Insightful article! Crosstalking multiple mechanistic pathways, events, processes with neuroscience is pivotal. Congratulations!!
May 30, 2025 at 8:47 PM
Thank you so much!!
May 27, 2025 at 3:08 PM
Alzheimer's disease is marked by the deposition of amyloid plaques and NFTs in the brain causing disrupted neurotransmission, which leads to cognitive impairment. However, such proteins aggregates are targeted by microglial cells, which in turn causes neuroinflammation leading to neurodegeneration 🔃
May 26, 2025 at 3:44 PM
I faced a similar experience when I presented my first RAC progress with the master's dissertation work and some preliminary findings from the initial months of the PhD. I hope you could find adequate results soon.
May 26, 2025 at 12:36 PM
Sharing the first review paper of my PhD journey, deciphering mechanistic insights into CKD and AD crosstalk. Published online on 9th May, and in issue on 21st May in ACS Chemical Neuroscience.
pubs.acs.org/doi/10.1021/...
The Vicious Consequences of Chronic Kidney Disease on Cognitive Impairment and Alzheimer’s Disease
Chronic kidney disease (CKD) and Alzheimer’s disease (AD) are two prevalent and debilitating conditions that frequently coexist, with CKD contributing to cognitive decline and potentially exacerbating...
pubs.acs.org
May 25, 2025 at 3:14 PM